×
About 126 results

ALLMedicine™ Supraglottic Cancer Center

Research & Reviews  63 results

The survival benefit of lymph node dissection in resected T1-2, cN0 supraglottic cancer...
https://doi.org/10.1002/hed.26596
Head & Neck; Fang R, Peng L et. al.

Dec 29th, 2020 - The survival benefit of clinically negative cervical lymph nodes (cN0) in patients with T1-2 supraglottic cancer (SC) remains unclear. This study aimed to comprehensively evaluate the prognostic value of lymph node dissection (LND) in patients wit...

Death unrelated to cancer and death from aspiration pneumonia after definitive radiothe...
https://doi.org/10.1016/j.radonc.2020.08.015
Radiotherapy and Oncology : Journal of the European Socie... Kanayama N, Otozai S et. al.

Aug 31st, 2020 - The incidence of hypopharyngeal and supraglottic cancer (HSC) is high in Japan. This study aimed to retrospectively identify risk factors for death unrelated to cancer and death from aspiration pneumonia after definitive radiotherapy (RT) for HSC....

Establishment and characterization of patient-derived xenografts as paraclinical models...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160896
BMC Cancer; Kang HN, Kim JH et. al.

Apr 15th, 2020 - We investigated whether head and neck squamous cell carcinoma (HNSCC) patient-derived xenografts (PDXs) reaffirm patient responses to anti-cancer therapeutics. Tumors from HNSCC patients were transplanted into immunodeficient mice and propagated v...

High pATM is Associated With Poor Local Control in Supraglottic Cancer Treated With Rad...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384019
The Laryngoscope; Bruine de Bruin L, Schuuring E et. al.

Apr 10th, 2020 - Most early stage laryngeal squamous cell carcinomas (LSCC) are treated with radiotherapy. Discovery of new biomarkers are needed to improve prediction of outcome after radiotherapy and to identify potential targets for systemic targeted therapy. T...

Rational choice of neck dissection in clinically N0 patients with supraglottic cancer.
https://doi.org/10.1002/hed.26014
Head & Neck REFERENCES; Zhang Y, Xu S et. al.

Nov 14th, 2019 - The mainstay treatment of the neck for clinically negative neck (cN0) supraglottic laryngeal carcinoma (SGLC) is neck dissection. However, the optimal extent remains controversial. This study's purpose is to determine whether ipsilateral level II-...

see more →

Clinicaltrials.gov  63 results

The survival benefit of lymph node dissection in resected T1-2, cN0 supraglottic cancer...
https://doi.org/10.1002/hed.26596
Head & Neck; Fang R, Peng L et. al.

Dec 29th, 2020 - The survival benefit of clinically negative cervical lymph nodes (cN0) in patients with T1-2 supraglottic cancer (SC) remains unclear. This study aimed to comprehensively evaluate the prognostic value of lymph node dissection (LND) in patients wit...

Death unrelated to cancer and death from aspiration pneumonia after definitive radiothe...
https://doi.org/10.1016/j.radonc.2020.08.015
Radiotherapy and Oncology : Journal of the European Socie... Kanayama N, Otozai S et. al.

Aug 31st, 2020 - The incidence of hypopharyngeal and supraglottic cancer (HSC) is high in Japan. This study aimed to retrospectively identify risk factors for death unrelated to cancer and death from aspiration pneumonia after definitive radiotherapy (RT) for HSC....

Establishment and characterization of patient-derived xenografts as paraclinical models...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160896
BMC Cancer; Kang HN, Kim JH et. al.

Apr 15th, 2020 - We investigated whether head and neck squamous cell carcinoma (HNSCC) patient-derived xenografts (PDXs) reaffirm patient responses to anti-cancer therapeutics. Tumors from HNSCC patients were transplanted into immunodeficient mice and propagated v...

High pATM is Associated With Poor Local Control in Supraglottic Cancer Treated With Rad...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384019
The Laryngoscope; Bruine de Bruin L, Schuuring E et. al.

Apr 10th, 2020 - Most early stage laryngeal squamous cell carcinomas (LSCC) are treated with radiotherapy. Discovery of new biomarkers are needed to improve prediction of outcome after radiotherapy and to identify potential targets for systemic targeted therapy. T...

Rational choice of neck dissection in clinically N0 patients with supraglottic cancer.
https://doi.org/10.1002/hed.26014
Head & Neck REFERENCES; Zhang Y, Xu S et. al.

Nov 14th, 2019 - The mainstay treatment of the neck for clinically negative neck (cN0) supraglottic laryngeal carcinoma (SGLC) is neck dissection. However, the optimal extent remains controversial. This study's purpose is to determine whether ipsilateral level II-...

see more →